Filing Flows › Cardlytics (CDLX) › Q2 2025
Cardlytics (CDLX) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 6, 2025
Cardlytics (CDLX) reported revenue of $63.2M for the second quarter 2025 (Q2 2025), -9% from a year earlier and +2% from the quarter before. Operating margin was -20.2%, net loss $9.3M (14.7% of revenue).
Cardlytics, Q2 2025: revenue $63.2M (-9% year over year), operating margin -20.2%, net loss $9.3M, operating cash flow $1.2M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $63.2M | +2% | -9% |
| Operating profit | −$12.8M | — | — |
| Net earnings | −$9.3M | — | — |
| Operating cash flow | $1.2M | — | -72% |
| Free cash flow | $903K | — | -78% |
What changed
Revenue was $63.2M in Q2 2025, down 9% year over year and up 2% from the previous quarter. Engagement based pricing was the largest line at 57% of revenue. Served based pricing lost $19.1M year over year (down 47%), 299% of the total change.
Operating costs exceeded revenue by $12.8M, an operating margin of -20.2%. Total costs fell 11% while revenue fell 9%. The quarter ended with a net loss of $9.3M, narrower than the previous quarter's $13.3M loss. Non-operating items added $3.5M, -38% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $1.2M (down 72% year over year). Non-cash charges added back $6.3M of depreciation and amortization and $7.5M of share-based compensation. Working capital and other items used $3.3M. Capital expenditures of $322K left free cash flow of $903K.
Questions
What was Cardlytics' revenue in the second quarter 2025?
Cardlytics (CDLX) reported revenue of $63.2M for the second quarter 2025 (Q2 2025), -9% from a year earlier and +2% from the quarter before.
Was Cardlytics profitable in the second quarter 2025?
Operating loss was $12.8M (-20.2% of revenue) and net loss $9.3M.
Source: Cardlytics 10-Q on SEC EDGAR.